Increased blood pressure after nonsevere COVID-19

Schmidt-Lauber, Christian; Alba Schmidt, Elisa; Hänzelmann, Sonja; Petersen, Elina L.; Behrendt, Christian-Alexander; Twerenbold, Raphael; Blankenberg, Stefan; Huber, Tobias B.; Wenzel, Ulrich O.

doi:10.1097/hjh.0000000000003522

Cited by 2 publications

(1 citation statement)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Second, in these studies, trends in the prevalence of hypertension were analyzed prior to 2019, and there is no data on how the coronavirus disease 2019 (COVID-19) pandemic has impacted these trends. This lack of data is of concern, as some evidence suggests that COVID-19 may favor the onset of hypertension ( 19 , 20 ) and that the related health crisis may have had deleterious effects on the management of hypertension ( 21 ). Third, to the best of the authors' knowledge, only one research has studied trends in the prescription of different antihypertensive drugs (e.g., angiotensin-converting enzyme inhibitors [ACEis], beta-blockers [BBs], and diuretics) ( 18 ).…”

Section: Introductionmentioning

confidence: 99%

Trends in hypertension and hypertension treatment in primary care in general practices in Germany between 2013 and 2022

Kostev,

Krieg,

Jacob

2024

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

BackgroundThere is a scarcity of data on the epidemiology of hypertension and its treatment in Germany in recent years.ObjectivesThe present study aimed to investigate trends in the number of adults diagnosed with hypertension and those being prescribed antihypertensive drugs each year in general practices from this country between 2013 and 2022.MethodsThis retrospective cohort study used data of adults aged ≥18 years continuously collected from 336 general practices in Germany (IQVIA) during 2013–2022. The diagnosis of hypertension and the prescription of antihypertensive drugs were coded using the ICD-10 and the EphMRA classification, respectively. Covariates included the total number of patients, mean (SD) age of patients, and proportion of women per practice. Trends in hypertension diagnosis and treatment were studied using linear regression models.ResultsThe mean (SD) total number of patients per practice ranged from 2,235 (1,055) in 2013–2,845 (2,090) in 2021 (p-value < 0.001). The mean (SD) age of patients per practice was between 48.4 (21.5) and 50.5 (21.4) years, while the proportion of women was 52.1%–53.9% (p-values < 0.001). After adjusting for covariates, there was a significant decrease in the number of patients diagnosed with hypertension (beta coefficient = −7.91, p-value < 0.001) and treated with any antihypertensive drug per practice per year between 2013 and 2022 (beta coefficient = −5.40, p-value < 0.001).ConclusionThis study identified decreasing trends in the diagnosis and treatment of hypertension in general practices in Germany in the last decade. These data may suggest that the prevention of hypertension has improved in this country in recent years.

show abstract

Section: Introductionmentioning

confidence: 99%

Trends in hypertension and hypertension treatment in primary care in general practices in Germany between 2013 and 2022

Kostev,

Krieg,

Jacob

2024

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

Predictors of the development of abnormal patterns of circadian blood pressure rhythm in patients with hypertension after a new coronavirus infection

Syuzeva,

Masalkina,

Koziolova

et al. 2024

Perm Medical Journal

View full text Add to dashboard Cite

Objective. To determine the predictors of the development of abnormal patterns of circadian blood pressure (BP) rhythm in patients with arterial hypertension (AH) after a new coronavirus infection (NСVI). Materials and methods. The study is a comparative clinical research of the same patients with hypertension before and after NCVI with retrospective evaluation of the data. Within 2 years from 842 patients with cardiovascular risk factors, according to the inclusion and non-inclusion criteria 70 patients with target levels of office BP, home monitoring and 24-hour blood pressure monitoring (ABPM) on the background of a continuous antihypertensive therapy were included in the study. Abnormal patterns of circadian BP were recorded after NCVI during ABPM in all of them. All patients with hypertension underwent a complete examination before and after NCVI. Results. After NCVI in patients with AH who had achieved the target ranges of office BP before its development, at home measurement and ABPM against the background of continuous antihypertensive therapy with high adherence to treatment, in more than 50 % of patients BP readings were not in the target values, in more than 50 % of the examined patients, BP variability was higher than the permissible values, in 73 % of patients the average daily BP was above 53 mm Hg. Abnormal patterns of circadian BP rhythm in patients with hypertension after NCVI were detected in 61.5 %: "Non-dipper" in 28.6 %; "Night-dipper" – in 21.9 %, masked nocturnal hypertension – in 17.1 %. Conclusion. The indicative significance of the development of abnormal patterns of circadian BP rhythm in patients with hypertension after NCVI was demonstrated by 3 qualitative indicators: glomerular filtration rate with cystatin C 60 ml/min/1.73 m2, cardio-ankle vascular index (CAVI) ≥ 9, and a high frequency of AGT gene polymorphism – T/T genotype (in 54.3 % of patients).

show abstract

Increased blood pressure after nonsevere COVID-19

Cited by 2 publications

References 43 publications

Trends in hypertension and hypertension treatment in primary care in general practices in Germany between 2013 and 2022

Trends in hypertension and hypertension treatment in primary care in general practices in Germany between 2013 and 2022

Predictors of the development of abnormal patterns of circadian blood pressure rhythm in patients with hypertension after a new coronavirus infection

Contact Info

Product

Resources

About